Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer
Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer
About this item
Full title
Author / Creator
FLAURA Investigators , Soria, Jean-Charles , Ohe, Yuichiro , Vansteenkiste, Johan , Reungwetwattana, Thanyanan , Chewaskulyong, Busyamas , Lee, Ki Hyeong , Dechaphunkul, Arunee , Imamura, Fumio , Nogami, Naoyuki , Kurata, Takayasu , Okamoto, Isamu , Zhou, Caicun , Cho, Byoung Chul , Cheng, Ying , Cho, Eun Kyung , Voon, Pei Jye , Planchard, David , Su, Wu-Chou , Gray, Jhanelle E , Lee, Siow-Ming , Hodge, Rachel , Marotti, Marcelo , Rukazenkov, Yuri and Ramalingam, Suresh S
Publisher
United States: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
United States: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
In 556 patients with previously untreated lung cancer bearing
EGFR
mutations, osimertinib and the first-generation EGFR inhibitors erlotinib and gefitinib had similar response rates, but osimertinib resulted in longer progression-free survival and had somewhat less toxicity.
Alternative Titles
Full title
Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer
Authors, Artists and Contributors
Author / Creator
Soria, Jean-Charles
Ohe, Yuichiro
Vansteenkiste, Johan
Reungwetwattana, Thanyanan
Chewaskulyong, Busyamas
Lee, Ki Hyeong
Dechaphunkul, Arunee
Imamura, Fumio
Nogami, Naoyuki
Kurata, Takayasu
Okamoto, Isamu
Zhou, Caicun
Cho, Byoung Chul
Cheng, Ying
Cho, Eun Kyung
Voon, Pei Jye
Planchard, David
Su, Wu-Chou
Gray, Jhanelle E
Lee, Siow-Ming
Hodge, Rachel
Marotti, Marcelo
Rukazenkov, Yuri
Ramalingam, Suresh S
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_1986452374
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1986452374
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJMoa1713137
